Introduction
TİTCK regulations and their impact on pharmacies in Turkey are central to understanding how Turkish pharmacy law operates in practice. The Turkish Medicines and Medical Devices Agency, known as TİTCK, is one of the most important regulatory authorities in the Turkish pharmaceutical and healthcare system. Its rules, announcements, guidelines and administrative practices directly affect pharmacies, pharmacists, pharmaceutical warehouses, marketing authorization holders, medicine suppliers, patients and healthcare institutions.
A pharmacy in Turkey is not an ordinary retail business. It is a licensed healthcare institution that operates under the ownership and professional responsibility of a pharmacist. For this reason, pharmacies are subject to a complex regulatory system involving licensing rules, medicine tracking obligations, prescription requirements, product recall procedures, market surveillance, inspection standards, promotion restrictions, pharmacovigilance, controlled medicines, pricing, supply continuity and patient safety.
TİTCK’s own legislation portal shows that the institution publishes and maintains a broad range of legal and administrative materials, including regulations, guidelines, procedures, systems and forms relevant to medicines, medical devices and pharmacy practice. The portal also includes references to systems such as Reçetem, İlaç Yan Etki Bildirimi, web applications and other TİTCK regulatory tools, showing the digital and operational character of modern pharmaceutical regulation in Turkey.
For pharmacies, TİTCK regulations create both obligations and protection. They impose compliance duties, but they also provide a structured framework for safe medicine supply, product traceability, prevention of counterfeit medicines, management of defective products and protection of public health.
The Legal Position of TİTCK in Pharmacy Regulation
TİTCK functions as the main regulatory and supervisory authority in many areas concerning medicines and medical devices in Turkey. The legal and administrative framework assigns TİTCK duties concerning medicines, biological products, traditional herbal medicinal products, homeopathic products, special medical purpose foods, product safety, quality, efficacy, promotion, unlicensed products, unavailable products, foreign medicine supply, off-label use, clinical trials and pharmaceutical warehouses.
This institutional role means that pharmacies are affected not only by the general provisions of Law No. 6197 on Pharmacists and Pharmacies, but also by TİTCK regulations and guidance. In practice, a pharmacy’s daily operation depends on systems and rules shaped by TİTCK, including the İlaç Takip Sistemi, medicine recall announcements, product safety controls, prescription classifications, market control rules and electronic notification obligations.
The impact of TİTCK is therefore both direct and indirect. Directly, TİTCK rules may impose specific duties on pharmacies, such as medicine tracking notifications. Indirectly, TİTCK decisions concerning product authorization, market withdrawal, pricing, product safety or supply shortages may affect what pharmacies can sell, how they manage stock and how they respond to patient demand.
TİTCK and the Regulation on Pharmacists and Pharmacies
One of the most important regulatory instruments for pharmacies is the Regulation on Pharmacists and Pharmacies. This regulation defines key concepts, including pharmacy, medicine, responsible manager, second pharmacist, assistant pharmacist, medicine tracking system and the institution itself. It identifies TİTCK as the “Kurum,” meaning the competent institution for many regulatory purposes.
The Regulation on Pharmacists and Pharmacies affects almost every aspect of pharmacy operation. It regulates pharmacy premises, technical requirements, pharmacy names and signs, duty pharmacy obligations, prescription acceptance, narcotic and psychotropic prescriptions, pharmacy records, medicine tracking, second pharmacist obligations, assistant pharmacist obligations, pharmacy employees and other daily compliance matters.
For pharmacies, this means that TİTCK-related regulation is not limited to extraordinary cases such as recalls or inspections. It shapes ordinary daily practice. A pharmacist must know how medicines are recorded, how prescriptions are accepted, how personnel are supervised, how revenue is declared through the system, how stock is reconciled and how pharmacy operations must be documented.
Impact on Pharmacy Licensing and Responsible Management
TİTCK regulations affect pharmacy licensing and responsible management by setting standards that connect professional responsibility with operational compliance. The Regulation on Pharmacists and Pharmacies treats the pharmacy as a healthcare institution operated under pharmacist ownership and responsible management. This model means that the pharmacist is legally accountable not only for commercial operation but also for regulatory compliance.
The concept of “responsible manager” is important. A pharmacy cannot be managed merely as a shop by ordinary employees or investors. The pharmacist must supervise the pharmacy’s legal and professional operation. TİTCK-related rules also affect the appointment of second pharmacists and assistant pharmacists. The Regulation requires a second pharmacist where annual prescription volume or turnover thresholds are exceeded, and it links turnover data to information reported to the institution.
The Regulation further provides that turnover information of private pharmacies must be declared by the pharmacy owner and responsible pharmacist through the İlaç Takip Sistemi every April. If turnover information is not declared, access to the medicine tracking system may be temporarily blocked until the declaration is made.
This is a significant practical impact. Without access to the medicine tracking system, a pharmacy’s lawful operation may be seriously disrupted. Therefore, a seemingly administrative requirement such as turnover declaration can have immediate operational consequences.
TİTCK and the Medicine Tracking System
The İlaç Takip Sistemi, known as İTS, is one of the most important TİTCK-related systems affecting pharmacies. The Regulation defines İTS as the system operated by TİTCK to track medicines through notifications starting from production or importation and continuing through each point of movement.
The Regulation requires pharmacies to use the medicine tracking system and make notifications for the purchase, sale, return to pharmaceutical warehouses, return to other warehouses in force majeure or closure situations, exchange between pharmacies, and destruction of expired or deteriorated human medicines. The Regulation also requires that the buyer shown in İTS notifications and the buyer shown in related documents must be the same.
This creates a strong traceability obligation. A pharmacy’s physical stock, invoices, electronic records and İTS notifications must be consistent. Any mismatch may create inspection risk, reimbursement risk, supply chain risk or suspicion of irregular medicine movement.
Recent TİTCK-related announcements also show the practical importance of İTS stock compliance. In 2025, TİTCK announced a stock equalization process to align İTS records with physical stock, requiring relevant stakeholders, including pharmacies, to correct discrepancies within the announced period. The announcement emphasized that stock equalization was important both for system integrity and legal obligations.
Impact on Stock Management and Internal Audit
Because of TİTCK’s İTS rules, pharmacies must operate with a continuous stock management culture. It is not enough for a pharmacy to know what products are physically on the shelves. The pharmacy must also know whether those products are correctly recorded in İTS, whether purchase notifications were properly made, whether returns were entered, whether expired products were removed and whether stock destruction procedures were documented.
This has transformed pharmacy compliance from a paper-based model into a digital traceability model. Pharmacies must train staff, reconcile stock regularly, control invoices, monitor expiry dates, prevent unauthorized transfers and ensure that any stock movement corresponds to a lawful transaction.
The legal risk is especially high for controlled medicines, cold-chain products, expensive medicines, imported medicines and products subject to recall. If İTS records do not match physical stock, the pharmacy may face questions during inspection or audit. Therefore, TİTCK regulations push pharmacies toward systematic internal audits and documented compliance procedures.
TİTCK and Prescription Rules
TİTCK regulations also affect prescription practice. The Regulation on Pharmacists and Pharmacies sets rules on prescriptions that may be accepted by pharmacies. Prescriptions must contain the patient’s name and surname, diagnosis, the physician’s name and surname, title, diploma registration number and place of duty, and must be signed by the physician. The Regulation recognizes normal prescriptions, special prescriptions for medicines requiring monitoring, electronic prescriptions and restricted prescriptions with security forms.
For pharmacies, this means that prescription compliance is not only a professional duty but also a regulatory obligation. The pharmacist must verify whether the prescription is acceptable, whether the medicine requires a special prescription category, whether the prescription is electronic, whether additional security documentation is needed and whether controlled medicine rules apply.
The Regulation also provides specific rules for narcotic and psychotropic prescriptions. Such prescriptions are not returned to the patient; one copy is kept at the pharmacy, and procedures are carried out according to institutional regulations.
This framework gives TİTCK a major role in prescription-related compliance. Pharmacies must follow not only general prescription law but also TİTCK’s evolving electronic systems, controlled medicine procedures and prescription monitoring rules.
TİTCK and Product Safety
TİTCK regulations directly affect product safety. The Regulation on Market Control of Human Medicinal Products states that its purpose is to determine the procedures, principles, duties, powers and responsibilities for planning, conducting and evaluating market control activities to ensure that licensed or authorized human medicinal products and special medical purpose foods are present in the market with the required effectiveness, safety and quality.
For pharmacies, market control has practical consequences. A medicine that appears lawful today may later become subject to market control measures, quality investigation, batch control, suspension, recall or withdrawal. Pharmacies must therefore monitor official announcements and respond quickly to TİTCK decisions affecting specific products, batches or product groups.
Product safety rules also protect pharmacists. When a product defect arises from manufacturing or authorization-holder issues, TİTCK’s market control and recall framework helps identify the source of the problem, organize the response and prevent unsafe products from remaining in circulation.
TİTCK and Product Recalls
Product recall is one of the most important regulatory processes affecting pharmacies. Although recall obligations primarily fall on marketing authorization holders or permit holders, pharmacies play a crucial role because they are the final professional point before medicines reach patients.
The 2024 framework concerning the recall of human medicinal products and special medical purpose foods defines recall as the collection of a defective or suspected defective product from specified levels of the distribution chain according to the recall level. It also explains concepts such as blocking product movement during evaluation and risk-based recall procedures.
For pharmacies, recall obligations require immediate operational action. When a recall notice is issued, the pharmacy must identify whether it has affected stock, separate or block the product, stop sale where required, follow return or destruction instructions, document the process and respond to official requests.
Failure to comply with recall instructions can expose a pharmacy to administrative and professional liability. More importantly, it may endanger patient safety. A recalled medicine may be defective in quality, safety, labeling, packaging or stability. Pharmacies must therefore treat recall notices as urgent legal and healthcare obligations.
TİTCK and Promotion Restrictions
TİTCK regulations also affect how medicines may be promoted. The Regulation on Promotional Activities of Human Medicinal Products governs promotional activities concerning human medicinal products, enteral nutrition products and medical foods. The regulation states that promotion to healthcare professionals may be conducted through promotional materials, scientific meetings and visits by product promotion representatives.
The same regulation restricts public promotion. It states that products cannot be directly or indirectly promoted to the public through media and communication environments open to the public, including the internet, except for limited announcements authorized by the institution.
This is highly relevant for pharmacies. Pharmacists are healthcare professionals and may receive product information through lawful channels, but pharmacies must avoid turning product information into unlawful public advertising. Social media posts, website content, online campaigns, discount announcements, product recommendations and medicine-related public messaging must be handled carefully.
Pharmacies should distinguish between lawful patient counseling and unlawful medicine promotion. A pharmacist may explain proper medicine use to a patient, but a pharmacy should not advertise prescription medicines to the public or create content that encourages unnecessary medicine use.
TİTCK and Online Medicine Sales
Although internet sale restrictions are mainly found in pharmacy legislation, they are closely connected to TİTCK’s broader regulatory mission. Turkish pharmacy law prohibits online or electronic sale of medicines and pharmacy-only products, and TİTCK’s regulatory environment reinforces this prohibition through medicine tracking, product safety and promotion controls.
For pharmacies, this means that e-commerce models are highly restricted. A pharmacy cannot treat prescription medicines or pharmacy-only medicines as ordinary online retail products. Social media orders, WhatsApp-based medicine supply, marketplace listings and online discount campaigns involving medicines may create serious legal risk.
Digital communication must be managed carefully. General health education may be possible within legal boundaries, but online medicine sale, direct product promotion or prescription steering through digital channels may trigger regulatory consequences.
TİTCK and Pharmacy Inspections
TİTCK also affects pharmacy inspections. The Regulation on Pharmacists and Pharmacies provides that pharmacies are inspected by TİTCK health inspectors or by pharmacists assigned by the provincial health directorate. Pharmacies are inspected at least twice per year and whenever necessary.
Inspection may cover license status, pharmacist presence, second pharmacist obligations, prescription records, narcotic and psychotropic medicine records, İTS notifications, expired medicines, storage conditions, cold-chain compliance, online sales, prescription collection, personnel records and pharmacy premises.
From a compliance perspective, this means pharmacies should not wait for inspection to correct deficiencies. TİTCK-related rules require continuous preparedness. If deficiencies are identified, the pharmacy may be given time to correct them depending on the nature of the violation, but repeated or serious violations may lead to more severe consequences.
TİTCK and Second Pharmacist Obligations
The Regulation on Pharmacists and Pharmacies connects TİTCK data and pharmacy staffing duties. Where a private pharmacy exceeds annual prescription number or annual turnover thresholds, employing a second pharmacist becomes mandatory. The Regulation states that previous-year institution data is used for prescription numbers, while turnover is based on VAT-excluded revenue reported to the institution.
This shows how TİTCK’s data systems affect employment obligations. A pharmacy’s turnover or prescription volume is not only a financial matter; it may trigger mandatory staffing duties. If the pharmacy meets the criteria but fails to employ a second pharmacist, the responsible pharmacist may be warned and given time to comply. Continued failure may result in suspension of the pharmacy license.
Therefore, pharmacies must monitor prescription volume, annual turnover, declaration deadlines and staffing requirements together. Failure to comply may directly affect the pharmacy’s operational authority.
TİTCK and Controlled Medicines
Controlled medicines require strict compliance. The Regulation on Pharmacists and Pharmacies includes special rules for narcotic and psychotropic medicines. These medicines must be processed under special prescription rules, and relevant prescription copies must be kept at the pharmacy.
TİTCK’s impact is especially strong in this field because controlled medicines raise public health, criminal law and diversion risks. Pharmacies must ensure that such medicines are stored, dispensed, recorded and tracked in accordance with the applicable rules.
Any discrepancy involving controlled medicines may have serious consequences. A stock mismatch, missing prescription copy, incorrect electronic notification or unlawful supply may trigger administrative, disciplinary and criminal scrutiny. For this reason, pharmacies should apply stricter internal controls for narcotic, psychotropic and monitored medicines.
TİTCK and Pharmacovigilance
Pharmacovigilance is another area where TİTCK regulations affect pharmacies. TİTCK maintains official systems and resources for adverse effect reporting, and its legislation portal includes İlaç Yan Etki Bildirimi among the relevant tools.
Pharmacists are often the first healthcare professionals to hear patient complaints about side effects, unexpected reactions or medicine-related problems. When a patient reports an adverse effect, the pharmacist should evaluate the situation, guide the patient and comply with applicable reporting rules.
This is not only a scientific responsibility. It is also a legal compliance obligation. Pharmacovigilance supports public health by helping authorities identify safety problems, update product information, take market control measures or initiate recalls when necessary.
TİTCK and Medicine Supply Problems
TİTCK’s mevzuat portal includes references to the İlaç Tedarik Sorunları Komisyonu, indicating the regulatory importance of medicine supply continuity.
Medicine supply problems directly affect pharmacies because patients usually experience shortages at the pharmacy counter. When a medicine is unavailable, the pharmacist must communicate accurately, avoid unlawful substitution, follow official guidance and ensure that patient safety is not compromised.
TİTCK decisions concerning supply shortages, foreign medicine supply or unavailable products may determine whether alternative routes are available. Pharmacies should avoid informal supply channels and should rely on lawful mechanisms when dealing with unavailable medicines.
TİTCK and Pricing Impact on Pharmacies
Medicine pricing is another area where TİTCK-related regulation affects pharmacies. The official pricing framework for human medicinal products includes reference pricing, currency-related rules and institutional price assessment mechanisms. The Ministry of Health has published materials concerning amendments to the Communiqué on prices of human medicinal products, including reference price calculation concepts.
For pharmacies, pricing rules affect sale prices, margins, patient expectations, reimbursement, stock value and commercial planning. A medicine price change can affect pharmacy inventory value, patient co-payment, SGK reimbursement and supply behavior.
Pharmacies must comply with official medicine prices and cannot manage medicines like free-priced ordinary retail goods. Pricing errors may create patient disputes, SGK problems or administrative concerns.
TİTCK and Market Authorization
Although pharmacies do not usually apply for marketing authorization, authorization rules affect what pharmacies may lawfully supply. TİTCK regulates medicines and related products to ensure that they are authorized, safe, effective and of required quality.
The market control regulation focuses on licensed or authorized products and special medical purpose foods being available in the market with the desired effectiveness, safety and quality.
This matters because pharmacies should not supply unauthorized, counterfeit, illegally imported or suspicious medicines. A product may be requested by a patient, advertised online or brought from abroad, but the pharmacist must act within Turkish law. Unauthorized supply may create serious legal consequences.
Practical Compliance Checklist for Pharmacies
A pharmacy in Turkey should build its compliance system around TİTCK regulations and related pharmacy legislation.
First, the pharmacy should maintain accurate İTS records and reconcile them with physical stock. Second, the pharmacist should declare required turnover information within the applicable period. Third, prescription rules should be checked carefully, especially for special, restricted, narcotic and psychotropic prescriptions. Fourth, pharmacy staff should be trained on İTS notifications, returns, recalls, expired products and controlled medicines.
Fifth, the pharmacy should monitor TİTCK announcements, TEB notices and provincial health directorate communications. Sixth, recalled or blocked products should be immediately separated from sale. Seventh, online medicine sales and unlawful promotion should be avoided. Eighth, second pharmacist obligations should be reviewed annually according to turnover and prescription data. Ninth, inspection records, personnel records and prescription archives should be kept properly. Tenth, adverse effect reports and product safety complaints should be handled through proper channels.
Legal Risks of Non-Compliance
Failure to comply with TİTCK-related rules may create multiple risks. Administrative sanctions may arise from inspection findings, İTS violations, failure to declare turnover, prescription irregularities, improper stock movement, recall non-compliance or online medicine sales. Professional disciplinary liability may arise where the pharmacist violates professional ethics or fails to supervise pharmacy operations.
Civil liability may arise if a patient is harmed by a recalled, expired, improperly stored or unlawfully supplied medicine. Criminal liability may arise in serious cases involving counterfeit medicines, controlled medicines, forged prescriptions, illegal supply chains or deliberate regulatory evasion.
The key point is that TİTCK compliance is not optional. It is part of the legal foundation of pharmacy practice in Turkey.
Frequently Asked Questions
What is TİTCK’s role in pharmacy regulation?
TİTCK is the main Turkish regulatory authority for medicines and medical devices. Its regulatory role affects pharmacies through medicine tracking, inspections, market control, product safety, recall procedures, prescription systems, promotion restrictions and related compliance obligations.
What is İTS and why is it important for pharmacies?
İTS is the medicine tracking system operated by TİTCK. Pharmacies must use it for medicine purchases, sales, returns, exchanges and destruction of expired or deteriorated medicines.
Can TİTCK-related rules affect pharmacy staffing?
Yes. The Regulation links second pharmacist obligations to annual prescription numbers and turnover data, and turnover is declared through İTS. Failure to comply with second pharmacist obligations may lead to license suspension consequences.
Do TİTCK rules affect product recalls?
Yes. Product recall procedures are part of the regulatory framework for defective or suspected defective products. Pharmacies must respond to recall notices by identifying affected stock, stopping sale where required and following return or destruction instructions.
Can pharmacies promote medicines online?
Pharmacies must be very cautious. The regulation on promotional activities restricts public promotion of human medicinal products, including through media and internet environments open to the public.
Conclusion
TİTCK regulations and their impact on pharmacies in Turkey are broad, practical and legally significant. TİTCK affects pharmacies through medicine tracking, prescription rules, product safety, market control, recalls, promotion restrictions, inspections, pharmacovigilance, supply issues, pricing and staffing-related data obligations.
For pharmacists, the most important point is that TİTCK compliance is part of daily pharmacy management. It is not limited to extraordinary inspections or rare product recalls. Every medicine purchase, sale, return, prescription, stock movement and digital record may have TİTCK-related consequences.
A legally compliant pharmacy should monitor TİTCK and TEB announcements, maintain accurate İTS records, respond immediately to recall notices, avoid unlawful promotion and online sales, comply with controlled medicine rules, declare turnover information on time, prepare for inspections and train employees continuously.
For patients, TİTCK regulations support medicine safety, traceability and public health. For pharmacists, they create a structured compliance system. For investors and healthcare businesses, they demonstrate that pharmacy practice in Turkey is not ordinary retail activity but a regulated healthcare service.
In Turkey, a pharmacy’s legal security depends not only on having a valid license but also on continuously complying with TİTCK rules, pharmacy legislation and official regulatory systems. TİTCK compliance is therefore one of the foundations of sustainable, lawful and safe pharmacy operation in Turkey.
Yanıt yok